
Mary M. Lyons
Examiner (ID: 1163, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1653, 1645 |
| Total Applications | 662 |
| Issued Applications | 371 |
| Pending Applications | 93 |
| Abandoned Applications | 224 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17625829
[patent_doc_number] => 20220160844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE
[patent_app_type] => utility
[patent_app_number] => 17/670702
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670702 | LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE | Feb 13, 2022 | Abandoned |
Array
(
[id] => 19656973
[patent_doc_number] => 20240424038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => BLUE-GREEN ALGAE-CONTAINING TABLET
[patent_app_type] => utility
[patent_app_number] => 18/273796
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273796
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273796 | BLUE-GREEN ALGAE-CONTAINING TABLET | Feb 9, 2022 | Pending |
Array
(
[id] => 17609901
[patent_doc_number] => 20220152180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => CHIMERIC VACCINE ANTIGENS FOR ANAPLASMOSIS
[patent_app_type] => utility
[patent_app_number] => 17/590290
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590290 | Chimeric vaccine antigens for anaplasmosis | Jan 31, 2022 | Issued |
Array
(
[id] => 18664881
[patent_doc_number] => 11771746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Method to reduce tick population with a universal tick antigen
[patent_app_type] => utility
[patent_app_number] => 17/922173
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5034
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922173 | Method to reduce tick population with a universal tick antigen | Jan 9, 2022 | Issued |
Array
(
[id] => 17760069
[patent_doc_number] => 20220233681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => LIVE ATTENUATED ORAL VACCINE AGAINST COVID-19 AND TYPHOID FEVER
[patent_app_type] => utility
[patent_app_number] => 17/566901
[patent_app_country] => US
[patent_app_date] => 2021-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17566901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/566901 | LIVE ATTENUATED ORAL VACCINE AGAINST COVID-19 AND TYPHOID FEVER | Dec 30, 2021 | Pending |
Array
(
[id] => 17503515
[patent_doc_number] => 20220096617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => ANTI-MALARIA COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/553098
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553098 | ANTI-MALARIA COMPOSITIONS AND METHODS | Dec 15, 2021 | Abandoned |
Array
(
[id] => 17625846
[patent_doc_number] => 20220160861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => VACCINE COMPOSITION AGAINST CHLAMYDIACEAE INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/552256
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552256 | Vaccine composition against Chlamydiaceae infections | Dec 14, 2021 | Issued |
Array
(
[id] => 17479764
[patent_doc_number] => 20220087268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/540823
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/540823 | BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY | Dec 1, 2021 | Pending |
Array
(
[id] => 20246709
[patent_doc_number] => 20250295578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => METHODS AND COMPOSITIONS FOR MICROBIAL TREATMENT OF SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/254961
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254961
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254961 | METHODS AND COMPOSITIONS FOR MICROBIAL TREATMENT OF SKIN DISORDERS | Nov 30, 2021 | Pending |
Array
(
[id] => 19930362
[patent_doc_number] => 12303555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
[patent_app_type] => utility
[patent_app_number] => 17/525804
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2133
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525804 | Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages | Nov 11, 2021 | Issued |
Array
(
[id] => 19701492
[patent_doc_number] => 12195501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Mutant fragments of OspA and methods and uses relating thereto
[patent_app_type] => utility
[patent_app_number] => 17/517477
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 25283
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517477 | Mutant fragments of OspA and methods and uses relating thereto | Nov 1, 2021 | Issued |
Array
(
[id] => 18915775
[patent_doc_number] => 11878041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Compositions and methods for treating the eye
[patent_app_type] => utility
[patent_app_number] => 17/515882
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12457
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17515882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/515882 | Compositions and methods for treating the eye | Oct 31, 2021 | Issued |
Array
(
[id] => 19677080
[patent_doc_number] => 12188934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Signatures and determinants for diagnosing infections and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/507994
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 108
[patent_no_of_words] => 60845
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507994 | Signatures and determinants for diagnosing infections and methods of use thereof | Oct 21, 2021 | Issued |
Array
(
[id] => 18215202
[patent_doc_number] => 11590115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/494068
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3041
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494068
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494068 | None | Oct 4, 2021 | Issued |
Array
(
[id] => 17518639
[patent_doc_number] => 20220104487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PSEUDOMONAS STRAINS AND THEIR METABOLITES TO CONTROL PLANT DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/493594
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493594 | Pseudomonas strains and their metabolites to control plant diseases | Oct 3, 2021 | Issued |
Array
(
[id] => 19903113
[patent_doc_number] => 12280097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/492190
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 8871
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492190 | Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of use | Sep 30, 2021 | Issued |
Array
(
[id] => 17312916
[patent_doc_number] => 20210401964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => NEISSERIA MENINGITIDIS VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/468989
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17468989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/468989 | Neisseria meningitidis vaccine | Sep 7, 2021 | Issued |
Array
(
[id] => 18675594
[patent_doc_number] => 20230313210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => ENGINEERED ORAL BACTERIA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/024647
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024647 | ENGINEERED ORAL BACTERIA AND USES THEREOF | Sep 2, 2021 | Pending |
Array
(
[id] => 19389725
[patent_doc_number] => 20240279595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => EXPRESSION HOST
[patent_app_type] => utility
[patent_app_number] => 18/007317
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007317
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007317 | EXPRESSION HOST | Aug 1, 2021 | Pending |
Array
(
[id] => 18751605
[patent_doc_number] => 20230354819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => Materials and Methods for Improving Plant Health
[patent_app_type] => utility
[patent_app_number] => 18/040362
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040362
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040362 | Materials and Methods for Improving Plant Health | Jul 29, 2021 | Pending |